Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegvisomant compassionate use in acromegaly
NCT00151437Phase 4Completed
- Sponsor
- Pfizer
- Start
- Nov 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of pegvisomant in acromegaly, sponsored by Pfizer. Primary endpoints: Patient's IGF-1 levels normalize and Signs and symptoms of acromegaly normalize. Started Nov 2004; status: completed.
02
Drugs
pegvisomant
03
Conditions
acromegaly
Beyond the preview
Go deeper on NCT00151437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00151437.